Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
TwitterLinkedinFacebookFeed
Next cycle of ICER appraisals selected - April 08

ICER held its inaugural meeting of the Topic Selection Committee on April 7th, 2008.  A total of 7 topics were discussed at the meeting (from an initial list of 20); committee members then voted for their highest-priority topics.  The 2 topics receiving the highest votes were 64-slice computed tomography angiography for detection of coronary artery disease, and pharmacogenetic testing for warfarin dosing, and will represent the next cycle of ICER reviews. 

Specifics on the topic selection process, as well as the original list of topics suggested:

April 2008 Topic Selection Specifics